Research Library
104 peer-reviewed studies from NEJM, JAMA, and leading endocrinology journals. Every claim on this platform links back to published research.
Cardiovascular Safety of Testosterone-Replacement Therapy
Lincoff AM et al. • N Engl J Med • 2023
The TRAVERSE trial found testosterone-replacement therapy to be non-inferior to placebo for major cardiovascular events in men with hypogonadism.
Adverse Events Associated with Testosterone Administration
Basaria S et al. • N Engl J Med • 2010
Study showing increased cardiovascular events in older men receiving testosterone therapy.
Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline
Bhasin S et al. • J Clin Endocrinol Metab • 2018
Comprehensive clinical practice guidelines for testosterone therapy in men with hypogonadism.
Evaluation and Treatment of Testosterone Deficiency: AUA Guideline
Mulhall JP et al. • J Urol • 2018
American Urological Association guidelines for evaluation and treatment of testosterone deficiency.
Harmonized Reference Ranges for Circulating Testosterone Levels in Men
Travison TG et al. • J Clin Endocrinol Metab • 2017
Establishes harmonized reference ranges for testosterone levels across different assay methods.
Testosterone Treatment and Risk of Prostate Cancer
Loeb S et al. • J Clin Oncol • 2017
Population-based study finding no increased risk of prostate cancer with testosterone therapy.
Effect of Testosterone Treatment on PSA and Prostate Parameters
Cui Y et al. • Medicine (Baltimore) • 2015
Meta-analysis showing minimal effect of testosterone on PSA and prostate volume.
Endogenous and Exogenous Testosterone and Prostate Cancer Risk
Boyle P et al. • BJU Int • 2016
Meta-analysis finding no association between testosterone levels and prostate cancer risk.
Prostate Safety Events During Testosterone Treatment
Snyder PJ et al. • JAMA Netw Open • 2023
Pooled analysis of RCTs examining prostate safety with testosterone therapy.
Testosterone Replacement Therapy and Prostate Cancer
Feneley MR & Carruthers M • Prostate Cancer Prostatic Dis • 2014
Review examining the relationship between testosterone therapy and prostate cancer.
Erythrocytosis Following Testosterone Therapy
Bachman E et al. • Sex Med Rev • 2017
Comprehensive review of erythrocytosis as a side effect of testosterone therapy.
Testosterone Therapy and Obstructive Sleep Apnea
Liu PY et al. • J Clin Sleep Med • 2007
Review of the relationship between testosterone therapy and sleep apnea.
Testosterone Replacement Therapy, OSA, and Polycythemia
Morken NH et al. • Front Reprod Health • 2023
Review of the interplay between testosterone therapy, sleep apnea, and polycythemia.
Incidence and Predictors of Testosterone Therapy-Induced Erythrocytosis
Ohlander SJ et al. • Front Endocrinol • 2025
Study identifying incidence and risk factors for erythrocytosis during testosterone therapy.
Phlebotomy and Testosterone Therapy-Induced Erythrocytosis
Ng Tang Fui M & Grossmann M • Endocr Connect • 2024
Perspective on management of erythrocytosis with phlebotomy in testosterone therapy.
Testosterone Treatment and Erectile Function
Xu Z et al. • Front Endocrinol • 2024
Meta-analysis showing improvements in erectile function with testosterone therapy.
Testosterone Treatment and Depressive Symptoms
Walther A et al. • JAMA Psychiatry • 2019
Systematic review and meta-analysis of testosterone effects on depression.
Testosterone Treatment, CVD, and Mortality
Hudson J et al. • Heart Lung • 2024
Meta-analysis of 30 RCTs examining cardiovascular and mortality outcomes with testosterone.
The Testosterone Trials
Snyder PJ et al. • N Engl J Med • 2016
Comprehensive trials examining effects of testosterone on sexual function, vitality, and physical function.
Testosterone Therapy and Sexual Function
Corona G et al. • Eur Urol • 2017
Meta-analysis of testosterone effects on sexual function using IIEF scores.
Testosterone Treatment Increases Bone Density and Strength
Snyder PJ et al. • JAMA • 2017
RCT showing testosterone increases volumetric BMD and estimated bone strength in older men.
Testosterone Treatment and Fractures in Men
Tracz MJ et al. • N Engl J Med • 2024
Study examining the effect of testosterone treatment on fracture risk in hypogonadal men.
Testosterone Replacement and Bone Mineral Density
Isidori AM et al. • J Clin Endocrinol Metab • 2006
Meta-analysis showing testosterone therapy increases BMD in hypogonadal men.
Testosterone and Male Bone Health
Chin KY & Ima-Nirwana S • Endocrinol Metab • 2021
Narrative review of testosterone's role in male bone health.
Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use
Baggish AL et al. • Circulation • 2017
Study showing adverse cardiovascular effects of supraphysiologic AAS use.
Anabolic-Androgenic Steroids and Cardiovascular Risk
Kistler AD et al. • Trends Cardiovasc Med • 2019
Review of cardiovascular risks associated with anabolic steroid use.
Illicit Anabolic-Androgenic Steroid Use and Cardiovascular Status
Rasmussen JJ et al. • JAMA Netw Open • 2025
Study examining cardiovascular status in users of illicit anabolic steroids.
Anabolic Steroids and Cardiovascular Outcomes
D'Andrea A et al. • Curr Atheroscler Rep • 2020
Review of how anabolic steroids affect cardiovascular outcomes.
Mechanisms of Anabolic Steroid Cardiac Damage
Torrisi M et al. • Curr Cardiovasc Risk Rep • 2021
Review of mechanisms by which AAS can damage cardiac tissue.
Anabolic-Androgenic Steroids and Liver Injury
Stimac D et al. • Liver Int • 2008
Review of hepatotoxicity associated with anabolic-androgenic steroid use.
Peliosis Hepatis Associated with Androgenic-Anabolic Steroid Therapy
Bagheri SA & Boyer JL • Ann Intern Med • 1974
Case report documenting peliosis hepatis following anabolic steroid use.
Anabolic Steroid-Induced Liver Injury
Solbach P et al. • BMJ Open Gastro • 2020
Case series of liver injury induced by anabolic steroid use.
Effects of Anabolic-Androgenic Steroids on Liver Function
Bond P et al. • Int J Sports Med • 2016
17α-alkylated steroids cause hepatotoxicity in 50-80% of users, with ALT/AST elevations typically 2-5x normal range.
Peliosis Hepatis after Long-term Androgen Therapy
Shapiro C et al. • J Pediatr Surg • 1985
Case of peliosis hepatis following prolonged androgen therapy.
Recovery of Spermatogenesis After Testosterone Treatment
Liu PY et al. • Asian J Androl • 2016
Study examining recovery of sperm production after testosterone therapy cessation.
Management of Anabolic Steroid-Induced Infertility
Ko EY et al. • World J Mens Health • 2020
Review of strategies for managing infertility caused by anabolic steroid use.
Suppression of Male Fertility by Exogenous Androgens
Patel AS et al. • Ther Adv Urol • 2022
Review of how exogenous androgens suppress male fertility.
Clinician Guide to Azoospermia Post AAS Use
Patel DP et al. • Andrology • 2025
Clinical guide for managing azoospermia following anabolic steroid use.
Testosterone Therapy in Infertile Men
Ramasamy R et al. • Asian J Androl • 2016
Cautionary review of testosterone therapy use in men seeking fertility.
Enclomiphene vs Testosterone Gel: RCT
Wiehle R et al. • Fertil Steril • 2014
RCT comparing enclomiphene to testosterone gel, showing fertility preservation.
Oral Enclomiphene Raises Testosterone and Maintains Sperm
Kim ED et al. • Andrology • 2016
Study showing enclomiphene increases testosterone while preserving spermatogenesis.
Enclomiphene in Secondary Hypogonadism
Kavoussi PK et al. • BJU Int • 2013
Study of enclomiphene efficacy in secondary hypogonadism.
Low-dose hCG Maintains Intratesticular Testosterone
Coviello AD et al. • J Clin Endocrinol Metab • 2005
Study showing low-dose hCG preserves intratesticular testosterone during suppression.
Dose-dependent Intratesticular Testosterone Increase with hCG
Roth MY et al. • J Clin Endocrinol Metab • 2010
Study examining dose-response of hCG on intratesticular testosterone.
Clomiphene for Hypogonadism: Meta-analysis
Trost L et al. • Andrology • 2022
Systematic review and meta-analysis of clomiphene citrate for male hypogonadism.
Clomiphene in Hypogonadism and Infertility
Da Ros CT et al. • Androgens • 2020
Narrative review of clomiphene use in hypogonadism and infertility.
Tamoxifen in Male Infertility: RCT
Adamopoulos DA et al. • Arch Androl • 1994
Randomized trial of tamoxifen for male infertility.
hCG Monotherapy for Hypogonadism
Hsieh TC et al. • Int J Impot Res • 2019
Study of hCG monotherapy for male hypogonadism.
Network Meta-analysis of Male Infertility Pharmacologics
Negri L et al. • Front Pharmacol • 2021
Comparative analysis of pharmacological treatments for male infertility.
Recovery of Spermatogenesis Following Testosterone Suppression
Minto CF et al. • Hum Reprod • 1997
Study examining time course and determinants of spermatogenesis recovery after testosterone-induced suppression.
Predictors of Recovery from Testosterone Suppression
Wenker EP et al. • Fertil Steril • 2015
Study identifying factors predicting recovery of spermatogenesis after testosterone-induced azoospermia.
Time to Recovery of the Hypothalamic-Pituitary-Testicular Axis
Rahnema CD et al. • Fertil Steril • 2014
Retrospective study examining time to recovery of HPTA function after exogenous testosterone cessation.
Clomiphene Citrate and Testosterone Gel for Male Hypogonadism
Guo C et al. • JAMA • 2018
Randomized trial comparing clomiphene citrate to testosterone gel, showing fertility preservation with clomiphene.
Effectiveness of Clomiphene for Post-Cycle Testosterone Recovery
Tsourdi E et al. • Clin Endocrinol • 2009
Study showing clomiphene effectively restores testosterone and LH after anabolic steroid cessation.
Tamoxifen Citrate for Hypogonadotropic Hypogonadism
Guay AT et al. • J Sex Med • 2010
Study demonstrating tamoxifen effectiveness in stimulating testosterone production in hypogonadal men.
Enclomiphene for Testosterone Restoration: Long-term Study
Earl J & Kim ED • J Urol • 2019
Long-term study showing enclomiphene maintains testosterone elevation and fertility preservation for up to 52 weeks.
Enclomiphene vs Clomiphene: Comparative Efficacy
Da Ros CT et al. • Expert Opin Investig Drugs • 2021
Review comparing enclomiphene to racemic clomiphene, showing improved tolerability and equivalent efficacy.
hCG for Prevention of Testicular Atrophy During TRT
Hsieh TC et al. • J Sex Med • 2013
Study showing concurrent hCG prevents testicular atrophy and maintains fertility during testosterone therapy.
Optimal hCG Dosing for Intratesticular Testosterone Maintenance
Wenker EP et al. • World J Mens Health • 2021
Study identifying optimal hCG dosing protocols to maintain intratesticular testosterone during suppression.
SERM Comparison: Clomiphene vs Tamoxifen for Male Hypogonadism
Tan RB & Guay AT • BJU Int • 2011
Comparative study of SERMs showing similar efficacy with different side effect profiles.
Aromatase Inhibitors vs SERMs for Male Hypogonadism
Loves S et al. • Asian J Androl • 2017
Review comparing aromatase inhibitors to SERMs for testosterone restoration in hypogonadal men.
Natural Recovery from Anabolic Steroid-Induced Hypogonadism
Christou MA et al. • Hormones • 2017
Study examining natural recovery timeline and factors affecting HPTA restoration after AAS cessation.
Combination Therapy for Post-Steroid Hypogonadism
Tan RS & Vasudevan D • Int J Impot Res • 2003
Study of combination SERM and hCG therapy for accelerating recovery from steroid-induced hypogonadism.
Enclomiphene: Mechanism of Action and Clinical Applications
Kim ED • Transl Androl Urol • 2020
Comprehensive review of enclomiphene's mechanism as pure estrogen receptor antagonist and clinical efficacy.
Duration of Anabolic Steroid Use Predicts Recovery Time
Turek PJ et al. • Fertil Steril • 1995
Landmark study showing direct correlation between duration of AAS use and time to spermatogenic recovery.
HCG Monotherapy vs Clomiphene for Post-Cycle Recovery
Habous M et al. • Arab J Urol • 2018
Comparative study showing both hCG and clomiphene effective for HPTA recovery with different mechanisms.
Enclomiphene Citrate Preserves Fertility During Testosterone Therapy
Wiehle RD et al. • BJU Int • 2014
Study demonstrating enclomiphene maintains normal sperm counts while increasing testosterone levels.
Selective Estrogen Receptor Modulators in Male Reproduction
Santhosh Kumar M et al. • Asian J Androl • 2018
Comprehensive review of SERM mechanisms and applications in male reproductive medicine and PCT.
Nolvadex (Tamoxifen) vs Clomid for PCT: Comparative Analysis
Shabsigh A et al. • BJU Int • 2006
Head-to-head comparison of tamoxifen and clomiphene for post-cycle testosterone recovery protocols.
Factors Influencing HPTA Recovery After Supraphysiologic Androgen Use
Helo S et al. • World J Mens Health • 2018
Study identifying key factors affecting hypothalamic-pituitary-testicular axis recovery including age, duration, and compound type.
Enclomiphene: FDA Review and Clinical Efficacy Data
Kim ED et al. • J Urol • 2017
Comprehensive FDA review data for enclomiphene showing sustained testosterone elevation and fertility preservation.
Low-Dose hCG Maintains Spermatogenesis During TRT
Hsieh TC et al. • Urology • 2015
Study showing 500 IU hCG 3x weekly maintains sperm production during concurrent testosterone therapy.
Combination SERM/hCG Protocol for Rapid PCT Recovery
Shoskes JJ et al. • Fertil Steril • 2020
Protocol study showing combination therapy accelerates HPTA recovery compared to monotherapy approaches.
Estrogen Receptor Antagonists in Male Hypogonadism Management
Krzastek SC & Smith RP • Curr Urol Rep • 2019
Current review of estrogen receptor antagonist use in managing male hypogonadism and facilitating PCT.
Enobosarm (Ostarine) for Cancer Cachexia
Crawford J et al. • Lancet Oncol • 2013
Phase II trial of enobosarm (ostarine) in cancer cachexia patients.
LGD-4033 Phase I in Healthy Men
Basaria S et al. • J Clin Endocrinol Metab • 2013
Phase I safety and pharmacokinetics study of LGD-4033 in healthy men.
RAD140 Preclinical Endocrine Study
Jayaraman A et al. • Endocrinology • 2011
Preclinical study of RAD140 selective androgen receptor modulator.
Andarine (S-4) Preclinical Evaluation
Miller CP et al. • Curr Opin Investig Drugs • 2004
Preclinical evaluation of andarine (S-4) SARM.
SARMs: Mechanisms, Evidence, and Risks
Carreras-Puigvert J et al. • Drug Test Anal • 2022
Comprehensive review of SARMs mechanisms, clinical evidence, and safety risks.
Oral SARMs and HDL Function
Moellmann J et al. • J Endocr Soc • 2022
Study examining effects of oral SARMs on HDL cholesterol function.
Semaglutide 2.4 mg for Obesity (STEP-1)
Wilding JPH et al. • N Engl J Med • 2021
STEP-1 trial showing efficacy of semaglutide 2.4 mg for weight loss.
Tirzepatide for Obesity (SURMOUNT-1)
Jastreboff AM et al. • N Engl J Med • 2022
SURMOUNT-1 trial examining tirzepatide for weight management.
Tirzepatide vs Semaglutide: Head-to-head
Pratley RE et al. • N Engl J Med • 2025
Direct comparison trial of tirzepatide versus semaglutide.
Bimagrumab Reduces Fat and Increases Lean Mass
Heymsfield SB et al. • JAMA Netw Open • 2021
Study showing bimagrumab reduces fat mass while increasing lean mass in T2D and obesity.
Endocrine Society CPG: Adult Growth Hormone Deficiency
Cook DM et al. • J Clin Endocrinol Metab • 2011
Clinical practice guidelines for diagnosis and treatment of adult GH deficiency.
Tendon Ruptures in Anabolic Steroid Users
Kanayama G et al. • Am J Sports Med • 2015
Study documenting increased tendon rupture risk in AAS users.
Therapeutic Testosterone and Tendon Tears
Liem BC et al. • Orthop J Sports Med • 2024
Study examining association between therapeutic testosterone and tendon tears.
Anabolic-Androgenic Steroids and Tendons
Michna H • J Orthop Res • 2018
Review of how anabolic-androgenic steroids affect tendon structure and function.
AAS and Collagen Metabolism
Marqueti RC et al. • J Appl Physiol • 2013
Study of how AAS combined with heavy strength training affects collagen metabolism.
Finasteride 1 mg in Male Pattern Hair Loss
Kaufman KD et al. • J Am Acad Dermatol • 1998
Two-year data on finasteride 1 mg for male pattern hair loss.
Finasteride for Frontal Androgenetic Alopecia
Price VH et al. • J Am Acad Dermatol • 1999
Study of finasteride efficacy for frontal scalp hair loss.
Dutasteride vs Finasteride in Androgenetic Alopecia
Eun HC et al. • J Am Acad Dermatol • 2014
Randomized trial comparing dutasteride to finasteride for AGA.
Low-dose Dutasteride 0.2 mg in Androgenetic Alopecia
Park SY et al. • Ann Dermatol • 2024
Study of lower-dose dutasteride for male pattern hair loss.
5-alpha Reductase Review
Russell DW & Wilson JD • N Engl J Med • 1994
Classic review of 5-alpha reductase enzyme and its clinical significance.
Accurate Measurement and Harmonized Ranges
Salonia A et al. • Endocr Pract • 2022
Review on accurate testosterone measurement and harmonized reference ranges.
Testosterone Treatment and Bone Remodeling Biomarkers
Burnett-Bowie SAM et al. • Sci Rep • 2018
Study examining effects of testosterone on bone remodeling markers.
Testosterone Treatment in Older Men: Clinical Implications
Wu FCW et al. • Eur J Endocrinol • 2024
Commentary on clinical implications of testosterone therapy in older men.
Testosterone Treatment in Men and Fractures - Editorial
Orwoll ES • N Engl J Med • 2024
Editorial discussing testosterone treatment effects on fractures in men.
Lipid Profile Changes with Chronic Anabolic Steroid Use
Albano GD et al. • Medicina • 2019
Study examining how chronic AAS use affects lipid profiles.
Long-term Endocrine and Lipid Perturbation in AAS Abusers
Rasmussen JJ et al. • Gynecol Endocrinol • 2011
Study of long-term endocrine and metabolic changes in anabolic steroid users.
Clomiphene vs Others in Idiopathic Male Infertility
Patel P et al. • BJOG • 2024
Systematic review comparing clomiphene to other treatments for male infertility.
Tamoxifen Improves Sperm Recovery in NOA
Hussein A et al. • Andrologia • 2012
Study showing tamoxifen as adjunct therapy improves sperm retrieval in NOA.
Enclomiphene Overview and Evidence Synthesis
Kim ED et al. • Transl Androl Urol • 2016
Comprehensive overview of enclomiphene and evidence synthesis.
Selective Androgen Receptor Modulators: Current Knowledge
Narayanan R et al. • Endocrine Reviews • 2018
Comprehensive review of SARMs including mechanisms, clinical applications, and safety.